Proqr Therapeutics (PRQR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 1,091 | 1,385 | 281 | 1,028 | 293 |
| Gross Profit | 1,091 | 1,385 | 281 | 1,028 | 293 |
| Operating Expenses | 17,838 | 20,395 | 20,278 | 18,194 | 16,201 |
| Operating Income | -16,747 | -19,010 | -19,997 | -17,166 | -15,908 |
| Interest Expense | 127 | 1,413 | 0 | 0 | 0 |
| Other Income | 1,283 | 4,215 | -989 | -563 | -3,009 |
| Pre-tax Income | -15,591 | -16,208 | -20,986 | -17,728 | -18,917 |
| Income Tax | 21 | 8 | 25 | 41 | 64 |
| Net Income Continuous | -15,612 | -16,216 | -21,011 | -17,769 | -18,981 |
| Minority Interests | 231 | -9 | -48 | N/A | -8 |
| Net Income | $-15,843 | $-16,207 | $-20,963 | $-17,769 | $-18,972 |
| EPS Basic Total Ops | -0.22 | -0.22 | -0.29 | -0.26 | -0.29 |
| EPS Basic Continuous Ops | -0.22 | -0.23 | -0.29 | -0.26 | -0.29 |
| EPS Diluted Total Ops | -0.22 | -0.22 | -0.29 | -0.26 | -0.29 |
| EPS Diluted Continuous Ops | -0.22 | -0.23 | -0.29 | -0.26 | -0.29 |
| EBITDA(a) | $-16,151 | $-18,370 | $-19,337 | $-16,556 | $-15,183 |